# Ovid Therapeutics Inc.: Form 8-K, filed Jun 28, 2024

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2024-06-28
- Accepted by EDGAR: Jun 28, 2024, 16:02 ET
- Period: 2024-06-27
- Accession: 0001193125-24-172225
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000119312524172225/d822326d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000119312524172225/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000119312524172225/d822326d8k.htm

Filed Jun 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-172225. Last ingested by Listed: Nov 10, 2026, 17:16 ET. No prices; not investment advice.
